Back to search

Article

Informing individualized multi-scale neural signatures of clozapine response in patients with treatment-refractory schizophrenia

2023-03-15

Abstract excerpt

<h4>ABSTRACT</h4> Clozapine is currently the only antipsychotic with demonstrated efficacy in treatment-refractory schizophrenia (TRS). However, response to clozapine differs widely between TRS patients, and there are no available clinical or neural predictive indicators that could be used to increase or accelerate the use of clozapine in patients who stand to benefit. Furthermore, it remains unclear how the neuro...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
cf31bd58-0699-5504-80a2-6669a82cd9e4
DOI
10.1101/2023.03.10.23286854
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Informing individualized multi-scale neural signatures of clozapine response in patients with treatment-refractory schizophreniaDOI 10.1101/2023.03.10.23286854
Select a neighboring publication to make it the new centre.